For research use only, not for therapeutic use.
Cangrelor Tetrasodium(Cat No.:M020881)is a fast-acting, intravenous P2Y12 platelet inhibitor used to prevent thrombosis during percutaneous coronary interventions (PCI) such as angioplasty. By selectively blocking the P2Y12 receptor on platelets, Cangrelor prevents platelet activation and aggregation, reducing the risk of clot formation in patients undergoing cardiac procedures. Its rapid onset and short half-life make it ideal for acute settings, as it provides immediate antiplatelet effects that are quickly reversible once the infusion is stopped. Cangrelor Tetrasodium is an important agent in managing thrombotic cardiovascular events.
Catalog Number | M020881 |
CAS Number | 163706-36-3 |
Synonyms | cangrelor tetrasodium |
Molecular Formula | C17H21Cl2F3N5Na4O12P3S2 |
Purity | ≥95% |
Storage | Store at -20°C |
IUPAC Name | tetrasodium;[dichloro(phosphonato)methyl]-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-oxidophosphoryl]oxyphosphinate |
InChI | InChI=1S/C17H25Cl2F3N5O12P3S2.4Na/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32;;;;/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32);;;;/q;4*+1/p-4/t8-,10-,11-,14-;;;;/m1..../s1 |
InChIKey | COWWROCHWNGJHQ-OPKBHZIBSA-J |
SMILES | CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)(C(P(=O)([O-])[O-])(Cl)Cl)[O-])O)O.[Na+].[Na+].[Na+].[Na+] |